Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Semaglutide 1.7mg subcutaneous
DRUG
2 trials
Sponsors
University Health Network, Toronto
, University of Colorado, Denver
Conditions
Kidney Transplant Recipient
Obesity/Therapy
Phase 2
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
Not yet recruiting
NCT06913023
University Health Network, Toronto
Kidney Transplant Recipient
Start: 2026-09-05
End: 2029-12-30
Target: 37
Updated: 2026-09-16
Phase 3
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
Not yet recruiting
NCT07021937
University of Colorado, Denver
Obesity/Therapy
Start: 2026-06-15
End: 2031-04-30
Target: 120
Updated: 2026-07-02